(St. Charles, MO - AgNewsWire) NOVUS International, Inc. and Chr. Hansen, Inc., two leaders in animal health and nutrition, signed an agreement last week at World Pork Expo (WPX). This agreement combines the strengths of both organizations with respect to sales and technical competencies to position BioPlus 2B® to the swine industry in the United States.
BioPlus 2B®, a direct fed microbial (DFM), contains two strains of Bacillus (Bacillus licheniformis and Bacillus subtilis). These Bacillus strains can improve the intestinal microbial balance of swine. Safety studies have proven that BioPlus 2B® strains are totally safe to animals and humans. The data was compiled into more than 5,000 pages to get final approval in the European Union for all swine categories. It makes BioPlus 2B® the most extensively documented microbial for swine.
“This partnership compliments our GEMS nutrition program and gut health management portfolio,” stated Dan Meagher, Vice President, Americas. “NOVUS International is focused on providing producers, nutritionists and veterinarians with ways to optimize pig health and performance.”
BioPlus 2B® is an effective means of helping balance bacterial populations in the intestinal tract to improve performance regardless of life stage. BioPlus 2B® is an effective DFM that increases live weight gain and improves feed conversion efficiency when used in nursery and grow-finish applications. BioPlus 2B® also helps improve overall intestinal health, improved average daily gain (ADG) and decreased mortality.
“The cooperation with NOVUS International immediately broadens our access to the swine market in the United States. We expect strong growth in sales with this cooperation”, explains Dr. Bill Braman, VP Marketing and Sales Animal Health & Nutrition, Chr. Hansen NA.